Got an idea that could change your clinical workflow for the better - but not sure where to start? This night is for you.

Join us for Healthcare Ideas Night, a collaboration between Cicada HealthTech Hub and Westmead Health Precinct. This casual, engaging evening is designed for clinicians, nurses, and allied health professionals who want to explore the first steps in turning smart ideas into real-world impact.

You’ll hear from experts in:

Intellectual property
Regulatory affairs
Product design and manufacturing
Investment and funding
Business development and communication

These pros will kick off with a fast-paced reverse pitch - explaining what they look for and how they can help bring ideas to life. Then it's your turn - grab a slice of pizza and a beverage of your choice, and ask the experts your commercialisation questions - med device in mind? Therapeutics on the brain? Digital tech in development - bring us your queries!

Expect good food, good people, and genuinely helpful conversations.

When: Wednesday 25 June, 4:30 - 7:30pm
Where: Level 4, IQ Building, 160 Hawkesbury Road, Westmead
Who it’s for: Clinicians, researchers, and allied health professionals at Westmead who are motivated to improve how things work, but aren’t sure where to start.

Come curious. Leave clearer on how to move your idea forward.

-----------

Don't miss this opportunity to gain valuable insights from industry experts and network with fellow health tech innovators.

Cicada Innovations is proud to be collaborating with the Westmead Health & Innovation District, Australia’s fastest-growing health and innovation precinct, for this commercialisation masterclass series. These masterclasses are to help bridge the gap between research and commercialisation.

Find out more about the Cicada HealthTech Hub

The Cicada HealthTech Hub is proudly supported by NSW Government and is part of the Westmead’s Health & Innovation District. The district includes 4 major hospitals, 4 world-leading medical research institutes, 2 university campuses and the largest research-intensive pathology service in NSW. By 2036, the number of full-time staff will increase to more than 50,000 and the number of students will expand to more than 10,000. Among the first projects for development is a viral vector advanced manufacturing facility to provide ground-breaking trial therapies for infections, cancer and genetic diseases.